Wanjala Walter

Wanjala Walter is currently the Commercial and Access Lead at Amring Pharmaceuticals Inc. Prior to this role, Wanjala held positions at Roche as a Product Access Specialist/KAM focusing on Oncology, particularly Breast Cancer with Herceptin, and at AstraZeneca Kenya as a Medical Sales Representative responsible for various products including Meronem, Symbicort, Zoladex, and the roll-out of the Oncology Access program. Wanjala also served as a Sales Manager at Micro Labs at HML, driving sales through a team of medical representatives. Wanjala Walter holds a Master's degree in Health Systems Management from Methodist University Kenya and Bachelor's degrees in Molecular Biochemistry from the University of Nairobi.